|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print September 19, 2002
Am J Physiol Heart Circ Physiol, 10.1152/ajpheart.00068.2002
Submitted on January 25, 2002
Accepted on September 12, 2002
1 Depto. of Fisiologia de la Fac. de Medicina, Universidad Autonoma de S.L.P., San Luis Potosi, San Luis Potosi, Mexico
2 Depto. de la Posgrado, Escuela Superior de Medicina del IPN, Mexico, DF, Mexico
* To whom correspondence should be addressed. E-mail: rrubio{at}uaslp.mx.
In isolated guinea pig hearts saline perfused at constant flow, adenosine A1, A2A and A3 (Ax)agonist covalently bound to a large polymer (POL; >> 2000 kDa) were intracoronarily administered and three effects were studied; dromotropic, vascular and inotropic. The rank order of potencies
were: dromotropic; POL-A2A<<<<POL-A1>POL-A3, while vascular and inotropic; POL-A2A
>POL-A1>>POL-A3 i.e. the rank order of potency for POL-Ax depends on the part of the coronary vascular network involved i. e. there is a vascular heterogeneity. The large size of POL-Ax prevents their extravascular diffusion and act solely in the endothelial luminal surface. This implies their cardiac effects are due to endothelial mediators. Inhibition of nitric oxide (NO) and prostaglandin(PG) synthesis with L-NAME and indomethacin respectively show that the three cardiac effects of POL-A1 were mediated by NO and PG, while for POL-A2A and POL-A3 the mediator was mainly NO but not PG. These results suggest that if a POL-Ax activated the corresponding endothelial Ax receptor subtype a different mediator would be produced.
This article has been cited by other articles:
![]() |
J. P. Headrick, B. Hack, and K. J. Ashton Acute adenosinergic cardioprotection in ischemic-reperfused hearts Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1797 - H1818. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |